ask="N/A"
ask_size="N/A"
average_daily_volume="1374960"
bid="N/A"
bid_size="N/A"
book_value="-0.1530"
change="+0.0123"
change_from_200_day_moving_average="-0.0113"
change_from_50_day_moving_average="0.0224"
change_from_52_week_high="-1.1277"
change_From_52_week_low="0.2740"
change_in_percent="+2.7333%"
close="0.4623"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.6540"
ebitda="-18.11M"
eps_estimate_current_year="-0.5500"
eps_estimate_next_quarter="-0.0900"
eps_estimate_next_year="-0.4500"
ex_dividend_date="N/A"
float_shares="48793000"
high="0.4700"
high_52_weeks="1.5900"
last_trade_date="2/21/2017"
last_trade_price="0.4623"
last_trade_size="300"
last_trade_time="4:02pm"
low="0.4450"
low_52_weeks="0.1883"
market_capitalization="31.31M"
moving_average_200_day="0.4736"
moving_average_50_day="0.4399"
name="BioPharmX Corporation. Common"
notes="N/A"
one_year_target_price="3.0000"
open="0.4700"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-2.3783%"
percent_change_from_50_day_moving_average="+5.0828%"
percent_change_from_52_week_high="-70.9245%"
percent_change_from_52_week_low="+145.5125%"
previous_close="0.4500"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="253.9484"
revenue="119999.00"
shares_outstanding="67719000"
short_ratio="1.9100"
stock_exchange="ASE"
symbol="BPMX"
volume="534574"
weeks_range_52="0.1883 - 1.5900"
